Internal Medicine, Cardiovascular Disease · Farmington, MO
NPI
1962586289
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
130 Westmount Dr
Farmington, MO, 63640
Phone (573) 756-1813
Groups this clinician bills Medicare through
Medicare paid, 2024
$801K
14,808 services
Medicare patients, 2024
1,339
Average age 74
Drug cost, 2024
$2.2M
20,172 prescriptions
Company payments, 2025
$548
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bryan D Piotrowski was code 99457 (e&m - miscellaneous), 2,183 times for 500 patients. In total Bryan D Piotrowski billed 14,808 services in 71 codes, and Medicare paid $801K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99457 E&M - Miscellaneous | Office | 2,183 | 500 | $37.70 | $82K |
| 99454 E&M - Miscellaneous | Office | 1,922 | 457 | $34.04 | $65K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,675 | 363 | $49.21 | $82K |
| 99214 Office E&M - Established | Office | 1,447 | 895 | $89.78 | $130K |
| 99458 E&M - Miscellaneous | Office | 842 | 278 | $30.87 | $26K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 557 | 239 | $37.48 | $21K |
| 93000 Electrocardiogram | Office | 498 | 444 | $10.22 | $5,092 |
| J2785 Injection, regadenoson, 0.1 mg | Office | 488 | 122 | $6.03 | $2,944 |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 468 | 121 | $48.80 | $23K |
| 93306 Echocardiography (TTE/TEE) | Office | 437 | 431 | $123.06 | $54K |
| 99453 E&M - Miscellaneous | Office | 432 | 432 | $14.29 | $6,174 |
| 93296 External Electrocardiographic Monitoring | Office | 362 | 128 | $13.69 | $4,957 |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 362 | 181 | $97.28 | $35K |
| 93793 Care Management/Coordination | Office | 357 | 25 | $8.01 | $2,861 |
| 93294 External Electrocardiographic Monitoring | Office | 283 | 99 | $20.71 | $5,862 |
By year: 2022 $429K for 7,190 services; 2023 $435K for 6,528 services; 2024 $801K for 14,808 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 86 | 13 | $8.40 | $722 |
| 85610 Clinical Chemistry | 86 | 13 | $4.20 | $361 |
Medicare prescription drug claims, 2024
In 2024, the drug Bryan D Piotrowski prescribed most often to Medicare patients was Furosemide, with 1,638 prescriptions and refills. In total Bryan D Piotrowski wrote 20,172 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Furosemide Generic | 1,638 | 3,466 | 415 | $5,858 |
| Metoprolol Succinate Generic | 1,604 | 3,617 | 421 | $16K |
| Amlodipine Besylate Generic | 1,444 | 3,261 | 372 | $6,330 |
| Atorvastatin Calcium Generic | 1,199 | 2,921 | 316 | $7,912 |
| Carvedilol Generic | 1,041 | 2,275 | 256 | $5,311 |
| Potassium Chloride Generic | 1,028 | 2,098 | 250 | $15K |
| Eliquis Apixaban | 994 | 1,549 | 212 | $881K |
| Clopidogrel Clopidogrel Bisulfate | 921 | 1,989 | 219 | $7,344 |
| Metoprolol Tartrate Generic | 810 | 1,785 | 198 | $3,991 |
| Losartan Potassium Generic | 806 | 1,926 | 230 | $6,355 |
| Lisinopril Generic | 693 | 1,705 | 206 | $4,024 |
| Hydrochlorothiazide Generic | 589 | 1,371 | 176 | $2,289 |
| Rosuvastatin Calcium Generic | 578 | 1,394 | 165 | $4,760 |
| Spironolactone Generic | 554 | 1,195 | 148 | $3,217 |
| Xarelto Rivaroxaban | 348 | 564 | 71 | $303K |
Brand drugs: - claims; generic drugs: 17,550 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bryan D Piotrowski $548 ($548 in general payments such as food, travel and fees) from 10 companies. The largest payer was Merck Sharp & Dohme LLC with $120.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 7 | $120 |
| Amgen Inc. AMGN | 5 | $81.26 |
| Boston Scientific Corporation BSX | 2 | $72.53 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $52.35 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $49.18 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $46.47 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $35.29 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $34.79 |
| Esperion Therapeutics, Inc. ESPR | 2 | $29.75 |
| Abiomed JNJ | 1 | $26.45 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.